logo

For the Inventor, By the Inventor

Shiga, Japan

Kiyoshi Furukawa

This inventor holds 13 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1980-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyoshi Furukawa. Retrieved from https://idiyas.com/inventor/kiyoshi-furukawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 84.6

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 178(Granted Patents)


Location History:

  • Ibaraki, JP (1980)
  • Shiga, JP (1991 - 1995)
  • Shiga-ken, JP (1999 - 2002)
  • Shiga-gun, JP (2004 - 2005)

Company Filing History:

goldMedal13 out of 129 
 
Dainippon Pharmaceutical Company, Limited
 patents

Years Active: 1980-2005

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6962921 - Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient (2005-11-08),
2. 6743803 - Medicines for the prevention and treatment of neurodegenerative diseases (2004-06-01),
3. 6372740 - 2-aryl-8-oxodihydropurine derivative, process for the producing the same, medicinal compositions containing the same, and intermediates thereof (2002-04-16),
4. 6277993 - Intermediates for 5-substituted-3-oxadiazolyl-1,6-Naphthyridin-2(1H)-one derivatives (2001-08-21),
5. 6172079 - 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives (2001-01-09),
6. 5972946 - Acetamide derivative, process for preparing the same, and a (1999-10-26),
7. 5424434 - Production on 3-oxadiazolyl-1,6-naphthyridine derivatives (1995-06-13),
8. 5424433 - Intermediates for 3-oxadiazoly-1,6-naphthyridine derivatives (1995-06-13),
9. 5367078 - 3-oxadiazolyl-1,6-naphthyridine derivatives (1994-11-22),
10. 5185338 - Medicament for treating cerebral insufficiency diseases, novel (1993-02-09),
11. 5041443 - Medicament for treating cerebral insufficiency diseases, novel (1991-08-20),
12. 5021421 - 2-(1-Piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for (1991-06-04),
13. 4237135 - 2-(4-Ethyl-1-piperazinyl)-4-phenylquinoline, process for preparation (1980-12-02),

Title: Kiyoshi Furukawa: Innovator in Neurodegenerative Disease Treatments

Introduction

Kiyoshi Furukawa is a prominent inventor based in Shiga, Japan, known for his significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. With a total of 13 patents to his name, Furukawa has made remarkable strides in developing innovative remedies aimed at improving cognitive health.

Latest Patents

Furukawa's latest patents include groundbreaking work on dementia remedies that utilize 2-aryl-8-oxodihydropurine derivatives as the active ingredient. These medicines are designed for the treatment or prevention of various forms of dementia, including Alzheimer-type dementia and cerebrovascular dementia. The compounds exhibit an extremely potent ameliorating effect on learning disorders and dementia, showcasing their potential in the pharmaceutical industry.

Career Highlights

Kiyoshi Furukawa is currently associated with Dainippon Pharmaceutical Company, Limited, where he continues to innovate and develop new treatments. His work has garnered attention for its potential to significantly impact the lives of individuals suffering from neurodegenerative diseases.

Collaborations

Furukawa has collaborated with notable colleagues, including Makoto Oka and Kazunori Ohno, to advance research and development in his field. Their combined expertise has contributed to the success of various projects aimed at enhancing cognitive health.

Conclusion

Kiyoshi Furukawa's dedication to innovation in the treatment of neurodegenerative diseases positions him as a key figure in the medical field. His patents and ongoing research efforts continue to pave the way for advancements that could improve the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…